SCHEMBL3650592

SCHEMBL3650592

COc1cccc(OCC2(C(C(=O)NC3CCCCC3)C3CCCCC3)Nc3cc(F)c(F)cc3N2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C19 P33261 1/20 0.53
RAB9A P51151 5/20 0.44
NPC1 O15118 4/20 0.44
POLB P06746 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ALDH1A1 P00352 2/20 0.41
NFKB1 P19838 1/20 0.41
CASP3 P42574 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3648320 0.92 MEN1 (0.51) SMN1; SMN2CYP1A2CYP3A4CYP2C19RAB9A
SCHEMBL3650741 0.92 MAPT (0.47) SMN1; SMN2CYP1A2CYP3A4CYP2C19RAB9A
SCHEMBL3650434 0.90 KMT2A (0.41) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL2912844 0.87 LMNA (0.49) SMN1; SMN2CYP1A2CYP3A4CYP2C19RAB9A
SCHEMBL3651333 0.86 NPC1 (0.42) SMN1; SMN2RAB9ANPC1POLBALDH1A1
SCHEMBL3651170 0.84 NPC1 (0.40) SMN1; SMN2RAB9ANPC1POLBMEN1
SCHEMBL3648088 0.84 MEN1 (0.48) SMN1; SMN2CYP1A2CYP3A4CYP2C19RAB9A
SCHEMBL3648565 0.84 MAPT (0.44) SMN1; SMN2CYP1A2CYP3A4CYP2C19RAB9A
SCHEMBL3645321 0.83 MEN1 (0.50) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL3653797 0.81 RAB9A (0.45) SMN1; SMN2RAB9ANPC1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188263-A1 BENZIMIDAZOLE DERIVATIVES USED AS FXR AGONISTS F. Hoffmann-Roche AG (CH) 2010-05-26 EP claimed
WO-2009027264-A1 BENZIMIDAZOLE DERIVATIVES USED AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-03-05 WO claimed
EP-2188263-A1 BENZIMIDAZOLE DERIVATIVES USED AS FXR AGONISTS F. Hoffmann-Roche AG (CH) 2010-05-26 EP disclosed
WO-2009027264-A1 BENZIMIDAZOLE DERIVATIVES USED AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-03-05 WO disclosed